Product Images Perampanel

This text provides information about a medication containing 10 mg of perampanel per ampoule. It should be stored at a temperature between 20° to 25°C (68° to 77°F). The usual dosage should be followed as per the accompanying prescribing guidelines. The medication should be kept out of reach of children. The prescription should be dispensed by Tara Pharmaceutical Meslnnnlhmieln Industries Ltd., and distributed by Sun Pharmaceutical.*

This text contains information about Perampanel tablets. It provides details on dosage, storage conditions, manufacturer information, and distribution details. It is recommended to refer to the accompanying prescribing information and to keep the medication out of the reach of children.*

Store Perampanel at 20° to 25°C (68° to 77°F) [See USP recommended controlled room temperature]. The usual dosage information can be found in the accompanying prescribing. Keep this and all medications out of the reach of children. The medication guide should be dispensed to each patient. Distributed by Taro Pharmaceuticals Industries Ltd., Haifa Bay, Israel 2624761 and Sun Pharmaceuticals Industries, Inc., Ganouy, NJ 08512. RXOn. Manufacturer's product number: 5257845-0225-0.*

This is a description of a medication package containing tablets of perampanel. The text provides guidance on how to store the medication and emphasizes keeping it away from children. Instructions for pharmacists are given to dispense the medication along with a medication guide provided by Taro Pharmaceutical Industries. The package is distributed by Sun Pharmaceutical Industries, and additional contact details are provided for further information.*

This data shows the median percentage reduction in seizures from baseline in three different studies evaluating the use of placebo and Perampanel. The reduction in seizures ranged from 8% to 21% across the studies. Different dosages of Perampanel (4mg/day, 8mg/day, 12mg/day) were examined in comparison to a placebo in these studies.*

This text provides data on the proportion of patients in a study categorized by different treatment groups (Placebo, Perampanel 4 mg/day, Perampanel 8 mg/day, Perampanel 12 mg/day) and levels of improvement from "Worse" to "<25", "25 to <50", "50 to <75", and "75 to 100". The figures such as 15 and 10 may represent percentages or counts.*

This text appears to be a table showing the proportion of patients in different treatment groups (%). The table includes data on patients in a placebo group and those treated with Perampanel (with N=81 and N=381, respectively). The proportions of patients falling into different percentage ranges are also displayed.*